Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.

Source:http://linkedlifedata.com/resource/pubmed/id/11751413

Cancer Res. 2001 Dec 15 61 24 8887-95

Download in:

View as

General Info

PMID
11751413